Hans van der Saag - Chief Executive Officer @ BioActor

Overview

Number of Portfolio Companies

Number of Founded Organizations

Number of Investments

invested in

obfuscation

. This investment -

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	BioActor	No	Series A - BioActor	obfuscated obfuscation

Number of Current Jobs

is the

Chief Executive Officer

Hub Name	CB Rank (Hub)
Dietary Supplements Companies With Less Than $500M in Revenue	9,800
European Union (EU) Biotechnology Companies with Early Stage Venture Funding	67,612
The Netherlands Investors	22,277
Biotechnology Early Stage Companies With Fewer Than 10 Employees	54,747
Dietary Supplements Startups	40,525
Dietary Supplements Companies With Fewer Than 50 Employees	9,234
Dietary Supplements Companies With Less Than $1B in Revenue	9,728
Maastricht Companies	59,913
Europe Startups Founded in 2005	82,173
The Netherlands Health Care Companies	22,653

Funding Round•

Jul 26, 2011

obfuscation

from Hans van der Saag and 3 other investors